Next report date
Report period
H2 2024
EPS estimate
0.00AUD
Revenue estimate
1.38 MAUD
−0.005AUD
−13.81 MAUD
5.12 B
About ALTERITY THERAPEUTICS LIMITED
Sector
CEO
David A. Stamler
Headquarters
Melbourne
Website
Employees (FY)
11
Founded
1997
ISIN
AU0000043945
FIGI
BBG000CDZM28
Alterity Therapeutics Ltd. is a clinical stage biotechnology company. It engages in the business of research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's, Huntington, Parkinson’s, and other neurological disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ATH is 0.006 AUD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange ALTERITY THERAPEUTICS LIMITED stocks are traded under the ticker ATH.
ALTERITY THERAPEUTICS LIMITED is going to release the next earnings report on Aug 30, 2024. Keep track of upcoming events with our Earnings Calendar.
ATH stock is 20.00% volatile and has beta coefficient of 2.92. Check out the list of the most volatile stocks — is ALTERITY THERAPEUTICS LIMITED there?
ATH earnings for the last quarter are 0.00 AUD per share, whereas the estimation was 0.00 AUD resulting in a −633.07% surprise. The estimated earnings for the next quarter are 0.00 AUD per share. See more details about ALTERITY THERAPEUTICS LIMITED earnings.
ALTERITY THERAPEUTICS LIMITED revenue for the last quarter amounts to 120.18 K AUD despite the estimated figure of 2.27 M AUD. In the next quarter revenue is expected to reach 1.45 M AUD.
Yes, you can track ALTERITY THERAPEUTICS LIMITED financials in yearly and quarterly reports right on TradingView.
ATH stock has risen by 20.00% compared to the previous week, the month change is a 50.00% rise, over the last year ALTERITY THERAPEUTICS LIMITED has showed a 25.00% decrease.
ATH net income for the last quarter is −6.51 M AUD, while the quarter before that showed −5.77 M AUD of net income which accounts for −12.69% change. Track more ALTERITY THERAPEUTICS LIMITED financial stats to get the full picture.
Today ALTERITY THERAPEUTICS LIMITED has the market capitalization of 31.43 M, it has increased by 10.00% over the last week.
No, ATH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ATH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALTERITY THERAPEUTICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 11.00 employees. See our rating of the largest employees — is ALTERITY THERAPEUTICS LIMITED on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ALTERITY THERAPEUTICS LIMITED technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ALTERITY THERAPEUTICS LIMITED stock shows the sell signal. See more of ALTERITY THERAPEUTICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ALTERITY THERAPEUTICS LIMITED future price: according to them, ATH price has a max estimate of 0.03 AUD and a min estimate of 0.01 AUD. Read a more detailed ALTERITY THERAPEUTICS LIMITED forecast: see what analysts think of ALTERITY THERAPEUTICS LIMITED and suggest that you do with its stocks.